These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38474872)

  • 1. Effects of Enteric-Coated Formulation of Sodium Bicarbonate on Bicarbonate Absorption and Gastrointestinal Discomfort.
    Jiang FL; Jeong DH; Eom SH; Lee HM; Cha BJ; Park JS; Kwon R; Nam JY; Yu HS; Heo SH; Kim CH; Song KH
    Nutrients; 2024 Mar; 16(5):. PubMed ID: 38474872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosage form design for improvement of bioavailability of levodopa VI: formulation of effervescent enteric-coated tablets.
    Nishimura K; Sasahara K; Arai M; Nitanai T; Ikegami Y; Morioka T; Nakajima E
    J Pharm Sci; 1984 Jul; 73(7):942-6. PubMed ID: 6088756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enteric-coated sodium bicarbonate supplementation improves high-intensity cycling performance in trained cyclists.
    Hilton NP; Leach NK; Hilton MM; Sparks SA; McNaughton LR
    Eur J Appl Physiol; 2020 Jul; 120(7):1563-1573. PubMed ID: 32388584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of serial and acute enteric-coated sodium bicarbonate supplementation on anaerobic performance, physiological profile, and metabolomics in healthy young men.
    Zhou N; Fan Y; Kong X; Wang X; Wang J; Wu H
    Front Nutr; 2022; 9():931671. PubMed ID: 36051902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative bioavailability and pharmacokinetics of investigational enteric- and film-coated formulations of flurbiprofen 100-mg tablets: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Pakistani male volunteers.
    Ahmad M; Pervaiz F
    Clin Ther; 2010 Mar; 32(3):607-13. PubMed ID: 20399997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute enteric-coated sodium bicarbonate has negligible effect on anaerobic performance but affects metabolomics and attenuates the gastrointestinal response.
    Zhou N; Fan Y; Wang X; Wang J; Wu H
    Front Physiol; 2022; 13():996381. PubMed ID: 36311224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and food impact assessment of ademetionine enteric-coated tablet as an endogenous substance drug in healthy Chinese volunteers.
    Zhang J; Liu H; Tang L; Lin H; Yao Y; Tong Y; Jin M; Wang K
    J Clin Pharm Ther; 2022 Jun; 47(6):738-744. PubMed ID: 34981547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
    Kambayashi A; Blume H; Dressman J
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability study of a new, sinking, enteric-coated ursodeoxycholic acid formulation.
    Simoni P; Cerrè C; Cipolla A; Polimeni C; Pistillo A; Ceschel G; Roda E; Roda A
    Pharmacol Res; 1995 Feb; 31(2):115-9. PubMed ID: 7596954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relative bioavailability of diclofenac after a single administration of a new multiple-unit formulation of enteric-coated pellets].
    Walter K; von Nieciecki A
    Arzneimittelforschung; 2001; 51(8):643-50. PubMed ID: 11556125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of bicarbonate buffer systems for dissolution characterization of enteric-coated proton pump inhibitor tablets.
    Shibata H; Yoshida H; Izutsu K; Goda Y
    J Pharm Pharmacol; 2016 Apr; 68(4):467-74. PubMed ID: 27019275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss.
    Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG
    Aust N Z J Med; 1977 Dec; 7(6):600-4. PubMed ID: 350214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and gamma scintigraphy evaluation of two enteric coated formulations of didanosine in healthy volunteers.
    Damle B; Ullah I; Doll W; Wiley G; Knupp C
    Br J Clin Pharmacol; 2002 Sep; 54(3):255-61. PubMed ID: 12236845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bioavailability of sulpiride taken as a film-coated tablet with sodium bicarbonate, cimetidine, natural orange juice or hydrochloric acid.
    Shinkuma D; Hamaguchi T; Kobayashi M; Yamanaka Y; Mizuno N
    Int J Clin Pharmacol Ther Toxicol; 1989 Oct; 27(10):499-502. PubMed ID: 2555311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics and IVIVC for mesalazine enteric-coated tablets.
    Zhang Y; Wo SK; Leng W; Gao F; Yan X; Zuo Z
    J Control Release; 2022 Jun; 346():275-288. PubMed ID: 35461968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of enteric-coated penicillamine tablets.
    Chambliss WG; Chambliss DA; Cleary RW; Jones AB; Harland EC; Kibbe AH
    J Pharm Sci; 1984 Sep; 73(9):1215-9. PubMed ID: 6333505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enteric-coated solid dosage forms containing sodium bicarbonate as a drug substance: an exception from the rule?
    Breitkreutz J; Gan TG; Schneider B; Kalisch P
    J Pharm Pharmacol; 2007 Jan; 59(1):59-65. PubMed ID: 17227621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
    Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
    Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteric coated quinidine compared to sustained release preparations during repeated administration.
    Bakke OM; Aanderud L; Aslaksen A
    Acta Med Scand; 1980; 207(3):183-7. PubMed ID: 7368984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.